Jean-Jacques Bienaim

2015

In 2015, Jean-Jacques Bienaim earned a total compensation of $13.6M as Chief Executive Officer at BioMarin Pharmaceutical, a 25% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$1,408,550
Option Awards$4,768,445
Salary$973,461
Stock Awards$6,436,584
Other$49,510
Total$13,636,550

Bienaim received $6.4M in stock awards, accounting for 47% of the total pay in 2015.

Bienaim also received $1.4M in non-equity incentive plan, $4.8M in option awards, $973.5K in salary and $49.5K in other compensation.

Rankings

In 2015, Jean-Jacques Bienaim's compensation ranked 282nd out of 13,638 executives tracked by ExecPay. In other words, Bienaim earned more than 97.9% of executives.

ClassificationRankingPercentile
All
282
out of 13,638
98th
Division
Manufacturing
101
out of 5,187
98th
Major group
Chemicals And Allied Products
43
out of 1,857
98th
Industry group
Drugs
37
out of 1,531
98th
Industry
Pharmaceutical Preparations
30
out of 1,179
98th
Source: SEC filing on April 25, 2017.

Bienaim's colleagues

We found four more compensation records of executives who worked with Jean-Jacques Bienaim at BioMarin Pharmaceutical in 2015.

2015

Henry Fuchs

BioMarin Pharmaceutical

President, Worldwide R&D

2015

Daniel Spiegelman

BioMarin Pharmaceutical

Chief Financial Officer

2015

Robert Baffi

BioMarin Pharmaceutical

Executive Vice President, Technical Operations

2015

Jeff Ajer

BioMarin Pharmaceutical

Executive Vice President, Chief Commercial Officer

News

You may also like